ImmunoPrecise Antibodies (IPA) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free IPA Stock Alerts C$6.50 +0.05 (+0.78%) (As of 11/25/2022) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineIPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024*finance.yahoo.com - March 14 at 8:39 AMImmunoPrecise Antibodies Ltd.: ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14finanznachrichten.de - December 7 at 12:37 PMBioStrand® Unveils a Revolutionary Approach to Biological Sequence Retrieval: A Fusion of Natural Language Processing and Database Researchbenzinga.com - November 13 at 9:38 AMEXCLUSIVE: Antibody-Discovery Platform Provider ImmunoPrecise's Subsidiary Highlights Approach to Biological Sequence Retrievalmsn.com - November 13 at 9:38 AMIPA Provides Update on Growth Strategy and Recent Share Price Movementfinance.yahoo.com - October 23 at 8:29 AMImmunoPrecise Antibodies Ltd. (IPA) Could Find a Support Soon, Here's Why You Should Buy the Stock Nowfinance.yahoo.com - October 11 at 12:49 PMImmunoPrecise Antibodies Ltd. (TQB.F)finance.yahoo.com - August 26 at 8:56 AMImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - July 13 at 12:45 PMBenchmark Reiterates ImmunoPrecise Antibodies (IPA) Speculative Buy Recommendationmsn.com - July 12 at 1:06 AMImmunoPrecise Antibodies Stock (NASDAQ:IPA), Guidance and Forecastbenzinga.com - May 17 at 9:07 PMImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2023 Earnings Call Transcripthk.finance.yahoo.com - March 21 at 12:25 AMImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Lags Revenue Estimatesfinance.yahoo.com - March 16 at 12:48 PMEarnings Outlook For ImmunoPrecise Antibodiesmsn.com - March 15 at 3:54 PMHere's Why We're Watching ImmunoPrecise Antibodies' (CVE:IPA) Cash Burn Situationfinance.yahoo.com - September 16 at 8:47 AMNIAID Confirms IPA's PolyTope TATX-03 Neutralizing Activity Against the Currently Spreading SARS-CoV-2 Variant BA.2.75stockhouse.com - September 16 at 1:40 AMImmunoPrecise Antibodies Ltd. (IPA) Q1 2023 Earnings Call Transcriptseekingalpha.com - September 16 at 1:40 AMNIAID Confirms IPA’s PolyTope TATX-03 Neutralizing Activity Against the Currently Spreading SARS-CoV-2 Variant BA.2.75nz.finance.yahoo.com - September 14 at 9:24 AMLive Virus Assays at Ludwig-Maximilians-Universität München Confirm PolyTope's Efficacy Against SARS-CoV-2 Variants Including BA.5stockhouse.com - August 30 at 7:04 PMImmunoPrecise antibody cocktail shows neutralizing activity versus Omicron BA.2 in lab testseekingalpha.com - April 20 at 10:03 AMImmunoPrecise Antibodies reports Q3 resultsseekingalpha.com - March 17 at 9:12 PMImmunoPrecise Antibodies and ChemPartner Biologics Announce PolyTope® TATX-03 Antibody Cocktail Manufacturing Collaborationyahoo.com - December 20 at 9:17 AMImmunoPrecise Update on its SARS-CoV-2 PolyTope™ Multi-Antibody Cocktail Development Programfinance.yahoo.com - November 30 at 8:17 AMImmunoPrecise Announces Participation at the H.C. Wainwright 23nd Annual Global Investment Conference on September 13-15, 2021 (Virtual Conference)stockhouse.com - September 7 at 8:51 AMUnusual Options Activity Insight: ImmunoPrecise Antibodiesbenzinga.com - August 4 at 6:10 PMImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2021stockhouse.com - July 28 at 8:27 AMImmunoPrecise's PolyTope(TM) TATX-03 Antibody Cocktail Potently Neutralizes SARS-CoV-2 Delta Variant in in vitro Pseudovirus Assaysstockhouse.com - July 23 at 4:19 PMImmunoPrecise’s TATX-03 Antibody Cocktail Potently Neutralizes Delta Variantnasdaq.com - July 23 at 4:19 PMImmunoPrecise’s PolyTope™ TATX-03 Antibody Cocktail Potently Neutralizes SARS-CoV-2 Delta Variant in in vitro Pseudovirus Assaysapnews.com - July 22 at 10:38 PMImmunoPrecise SkyRockets On Delta Variant Therapy News: What's Next?benzinga.com - July 22 at 10:38 PMWhy ImmunoPrecise Antibodies Stock Is Soaring Todaybenzinga.com - July 22 at 5:37 PM Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Email Address The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him IPA Media Mentions By Week IPA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPA News Sentiment▼0.000.41▲Average Medical News Sentiment IPA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPA Articles This Week▼00▲IPA Articles Average Week Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sernova News Today Medicenna Therapeutics News Today Oncolytics Biotech News Today Theratechnologies News Today ProMIS Neurosciences News Today Small Pharma News Today Microbix Biosystems News Today Fennec Pharmaceuticals News Today Cardiol Therapeutics News Today Zentek News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:IPA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
